skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Antiplatelet combinations for prevention of atherothrombotic events

Review

(2421) Views  (1069) Full article downloads

Authors: Mario Bollati, Fiorenzo Gaita, Matteo Anselmino

Published Date January 2011 Volume 2011:7 Pages 23 - 30
DOI: http://dx.doi.org/10.2147/VHRM.S12271

Mario Bollat,i Fiorenzo Gaita, Matteo Anselmino
Department of Internal Medicine, Division of Cardiology, University of Torino, Italy

Abstract: Antiplatelet therapy plays a fundamental role in reducing atherothrombotic events by several pathways. The present work reviews available evidence on antiplatelet therapy both for primary prevention and in the presence of established peripheral, cerebral, or cardiac ischemic disease. Due to the importance of adherence to therapy to achieve optimal effects, special attention is given to the use of fixed-dose oral formulations in the clinical subset of patients in whom double antiplatelet therapy has proven indications.

Keywords: aspirin, clopidogrel, ticlopidine, fixed-dose combinations

 








Readers of this article also read:

  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University